Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-01-10

Clinical Trial Update: Fluoxetine Essay in Children With Autism [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating fluoxetine in children with autism has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine (Fluoxetine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Autism | Phase 2 | Status: WITHDRAWN